The FDA recently mandated that Bayer Pharmaceuticals change the warning labels on two of its most popular birth control pills to reflect recent research relating to blood clots as a result of Yasmin or Yaz. The decision comes in the midst of many ongoing lawsuits... Read More

A New Mexico resident, Stephanie Brazil, has filed a lawsuit in the United States District Court for the Southern District of Illinois against drug maker Bayer Pharmaceuticals, the company responsible for the manufacture and marketing of the popular fourth generation drospirenone-based birth control known as... Read More

On May 22, 2012, Yaz litigation filed by Ellen and Warren Hollingsworth was transferred to federal multidistrict litigation in the U.S. District Court for the Southern District of Illinois (East St. Louis). The Mississippi residents charge Bayer Healthcare Pharmaceuticals with failure to warn the public... Read More

The manufacturer of the once-popular fourth generation birth control pill Yaz has been forced to pay out about $142 million in settlements to patients who have filed lawsuits after experiencing serious side effects as a result of their use of the birth control. Plaintiffs who... Read More

The Yaz multidistrict litigation in Illinois has gained another lawsuit. The new lawsuit against Bayer, manufacturer of Yaz and Yasmin, was filed on May 15, 2012 in the U.S. District Court for the Southern District of Illinois (East St. Louis), by Massachusetts resident Janet Mahon,... Read More

A California lawsuit has been filed claiming that the manufacturers of the birth control Yasmin should be held responsible for the serious side effects that its patients have endured and that the product is inherently dangerous for human consumption. The lawsuit, which was filed on... Read More

On May 7, 2012, New York residents Angela Wright and her husband filed a Yasmin lawsuit in the U.S. District Court for the Northern District of New York. The lawsuit states that Angela Wright developed a blood clot from Yaz, an oral contraceptive. The U.S.... Read More

A FDA advisory panel recently released an announcement stating that drug manufacturer Bayer didn’t adequately warn patients about the potential side effects of the oral contraceptive Yaz. The vote, which was cast on the 8th of December, 2011, was 21 to 5, and the advisory... Read More